Durvalumab after chemoradiotherapy in stage III NSCLC: 4-year survival update from the phase III PACIFIC trial
Author
Vansteenkiste, J. F.
Faivre-Finn, C.
Vicente, D.
Kurata, T.
Planchard, D.
Paz-Ares, L.
Spigel, D. R.
Garassino, M. C.
Reck, M.
Senan, S.
Naidoo, J.
Rimner, A.
Wu, Y-L.
Gray, J. E.
ÖZGÜROĞLU, Mustafa
Lee, K. H.
Newton, M.
Wang, L.
Thiyagarajah, P.
Antonia, S. J.
Metadata
Show full item recordCollections
- Bildiri [63306]